510(k) |
Medical Device Premarket Notification |
AADA |
Abbreviated Antibiotic Drug Application |
AALAC |
Asso. For Assessment & Accreditation of Lab. Animal Care Int'l |
AAPS |
American Association of Pharmaceutical Scientists |
Abifarma |
Brazilian Pharmaceutical Industry Association |
ABPI |
Association of British Pharmaceutical Industries |
ACCP |
American College of Clinical Pharmacology |
ACE |
Adverse Clinical Event |
ACRA |
Associate Commissioner for Regulatory Affairs |
ACRPI |
Association for Clinical Research in the Pharmaceutical Industry (UK) |
ACT |
Applied Clinical Trials |
ADE |
Adverse Drug Event, Adverse Drug Effect |
ADEC |
Australian Drug Evaluation Committee |
ADI |
Acceptable Daily Intake |
ADME |
Absorption, Distribution, Metabolism, and Excretion |
ADR |
Adverse Drug Reaction |
ADRAC |
Adverse Drug Reaction Advisory Committee (Australia) |
AERS |
Adverse Event Reporting System (FDA) |
AFDO |
Association of Food and Drug Officials |
AHA |
Area health Authority |
AHCPR |
Agency for Health Care Policy and Research |
AICRC |
Association of Independent Clinical Research Contractors (UK) |
AME |
Absorption, Metabolism, Excretion |
AMG |
Arzneimittelgesetz (German Drug Law) |
ANADA |
Abbreviated New Animal Drug Application |
ANDA |
Abbreviated New Drug Application |
ANSI |
American National Standards Institute |
AOAC |
Association of Official Analytical Chemists |
APHIS |
Animal and Plant Health Inspection Service |
API |
Active Pharmaceutical Ingredients |
APIFARM A |
Association of the Portuguese Pharmaceutical Industries |
AQL |
Acceptable Quality Level |
ARENA |
Applied Research Ethics National Association |
ASC |
Advertising Standards Council (Canada) |
ASCPT |
American Society for Clinical Pharmacology and Therapeutics |
ASQC |
American Society for Quality Control |
ATC |
Anatomical Therapeutic Chemical (WHO) |
ATF |
Alcohol, Tobacco, and Firearms (Bureau of) |
ATSDR |
Agency for Toxic Substances & Disease Registry |
AVEG |
AIDS Vaccine Evaluation Group |
BAPP |
British Association of Pharmaceutical Physicians |
BARQA |
British Association of Research Quality Assurance |
BBR |
Bureau of Biologicals and Radiopharmaceuticals (Canada) |
BCE |
Beneficial Clinical Event |
BCE |
Bureau of Compliance and Enforcement (Canada) |
BDS |
Bureau of Drug Surveillance (Canada) |
BFAD |
Bureau of Food and Drugs (Philippines) |
BfArM |
Germany's Ministry of Health |
BGA |
Bundesgesundheitsamt (German Public Health Agency) |
BGMA |
The British Generic Manufacturer's Association |
BMA |
British Medical Association |
BIO |
Biotechnology Industry Association |
BIRA |
The British Institute of Regulatory Affairs |
BMI |
Body Mass Index |
BPA |
Bureau of Pharmaceutical Assessment (Canada) |
BPC |
Bureau of Policy and Coordination (Canada) |
CA |
Corrective Action |
Cas |
Competent Authorities (EU) |
CANDA |
Computer Assisted New Drug Application |
CANDS |
Computer-Assisted New Drug Submission (Canada) |
CAPLA |
Computer Assisted Product License Application |
CAPLAR |
Computer Assisted Product License Agreement Review (FDA) |
CAPRA |
Canadian Association of Pharmaceutical Regulatory Affairs |
CBER |
Center for Biologics Evaluation and Research |
CCOHTA |
Canadian Coordinating Office of Health Technology Assessment |
CDC |
Centers for Disease Control and Prevention |
CDER |
Center for Drug Evaluation and Research |
CDRH |
Center for Devices and Radiological Health |
CDSA |
Controlled Drugs and Substances Act (Canada) |
CE Mark |
French for Conformite Europeene |
CERFA |
Centre d'Etudes et de Reformes de Formulaires Administratifs (FRANCE) |
CFR |
Code of Federal Regulations |
CFSAN |
Center for Food Safety and Applied Nutrition |
CIB |
Clinical Investigator's Brochure |
CIOMS |
Council for International Organizations of Medical Sciences (WHO) |
CM |
Chemistry and Manufacturing (Canada) |
CMC |
Chemistry and Manufacturing Controls |
CNS |
Central Nervous System |
COP |
Clinical Operating Plan (Japan) |
CPAC |
The Central Pharmaceutical Affairs Council (Japan) |
CPID |
Certified Product Information Document (Canada) |
CPMP |
Committee for Proprietary Medicinal Products (EMEA) |
CPS |
Compendium of Pharmaceuticals and Specialists (Canada) |
CSD |
Committee on Safety of Medicines (UK) |
CRA |
Clinical Research Associate |
CRC |
Clinical Research Coordinator |
CRO |
Contract Research Organization |
CSA |
Clinical Study Agreement |
CSDD |
Center for the Study of Drug Development |
CSI |
Consumer Safety Inspector |
CSM |
Committee on Safety of Medicines (UK) |
CSO |
Consumer Safety Officer |
CSR |
Clinical Study Report |
CTA |
Clinical Trial Application |
CTC |
Clinical Trial Certificate |
CTFA |
Cosmetic,Toiletry and Fragrance Association |
CTX |
Clinical Trial Exemption |
CUF |
Commissione Unica del Farmaco (Italy) |
CUVP |
The Committee for Veterinary Medicinal Products (EMEA) |
CVM |
Center for Veterinary Medicine |
DAL |
Defect Action Level |
DB |
Double-Blind |
DCF |
Data Clarification Request Form |
DD |
District Director |
DD |
Department of Drugs (Swedish Regulatory Agency) |
DDMAC |
Division of Drug Marketing, Advertising, and Communications |
DEA |
Drug Enforcement Administration |
DEN |
Drug Experience Network |
DESI |
Drug Efficacy Study Implementation |
DGD |
Now OGD (Formerly CBER's Division of Generic Drugs) |
DGFPS |
Generic Directorate of Pharmacy of Healthcare Products (SPAIN) |
DHHS |
Department of Health and Human Services |
DHR |
Device History Record |
DIA |
Drug Information Association |
DIN |
Drug Identification Number (Canada) |
DMA |
Danish Medicines Agency |
DMF |
Drug Master File |
DMR |
Device Master Record |
DOE |
Division of Enforcement (CDRH) |
DPL |
Drug Product Licensing (Canada) |
DRF |
Dose Range Finding (Study) |
DRG |
Diagnosis Related Groups |
DSMB |
Data and Safety Monitoring Board |
DTC |
Direct-to-Consumer |
DTP |
Direct-to-Patient |
EAB |
Ethical Advisory Board |
EAC |
Expert Advisory Committee (Canada) |
EC |
European Commission |
EEA |
European Economic Area |
EFGCP |
European Forum on Good Clinical Practice (Evere, Belgium) |
EFPIA |
European Federation of Pharmaceutical Industry Associations |
EFTA |
European Free Trade Association |
EIR |
Establishment Inspection Report |
ELA |
Establishment License Application |
EMEA |
European Medicines Evaluations Agency |
EOP1 |
End-of-Phase1 |
EOP2 |
End-of-Phase2 |
EPA |
Environmental Protection Agency |
EPAR |
European Public Assessment Reports |
EPL |
Effective Patent Life |
EPO |
European Patent Office |
EPRG |
European Pharmacovigilance Research Group |
ESRA |
European Society of Regulatory Affairs |
EUCOMED |
European Confederation of Medical Devices Association |
Farmindu stria |
The Association of the Italian Pharmaceutical Manufacturers |
FDC |
Food, Drug, & Cosmetic |
FDLI |
The Food and Drug Law Institute |
FOI |
Freedom of Information |
FOIA |
Freedom of Information Act |
FPIF |
The Finnish Pharmaceutical Industry Association |
FR |
Federal Register |
Fr.P. |
The French Pharmacopoeia (Pharmacopee Francaise) |
FSIS |
Food Safety and Inspection Service |
FTC |
Federal Trade Commission |
FTE |
Full Time Equivalent (employee) |
FTC |
Federal Trade Commission |
FTIM |
First-time-in-man |
FU |
Farmacopea Ufficiale, the Italian Pharmacopoeia |
FY |
Fiscal Year |
GAO |
General Accounting Office |
GATT |
General Agreement on Tariffs and Trade |
GCP |
Good Clinical Practice |
GGP |
Good Guidance Practices |
GLIN |
Global Legal Information Network |
GLP |
Good Laboratory Practice |
GMO |
Genetically Modified Organisms (EMEA) |
GMP |
Good Manufacturing Practice |
GPMSP |
Good Postmarketing Surveillance Practice (Japan) |
GRAS |
Generally Recognized as Safe (food ingredients) |
GSP |
Good Statistics Practice |
HACCP |
Hazard Analysis Critical Control Point (inspection technique) |
HDE |
Humanitarian Device Exemption |
HHS |
US Department of Health and Human Services |
HIMA |
Health Industry Manufacturer's Association |
HIV |
Human Immunodeficiency Virus |
HPB |
Health Protection Board (Canada) |
IB |
Investigator's Brochure |
IC |
Informed Consent |
ICDRA |
International Conference of Drug Regulatory Authorities |
ICH |
International Conference on Harmonization |
IDE |
Investigational Device Exemption |
IDR |
Idiosyncratic Drug Reaction |
IEC |
Independent Ethics Committee |
ILAR |
Institute for Laboratory Animal Research |
IMB |
The Irish Medicines Board |
IMDA |
Irish Medical Device Association |
INADA |
Investigational New Animal Drug Application |
IND |
Investigational New Drug (application) |
INDC |
Investigational New Drug Committee |
INFARME D |
Instituto Nacional da Farmacia e do Medicamento (Portugal) |
INN |
International Approved Names for Pharmacopoeial Substances |
IPRO |
Independent Pharmaceutical Research Organization |
IPU |
Irish Pharmaceutical Union |
IRB |
Institutional Review Board |
IRC |
Institutes Review Committee |
IRD |
International Registration Document |
ISE |
Integrated Summary of Efficacy |
ISO |
International Standards Organization |
ISPE |
International Society of Pharmaceutical Engineers |
ITT |
Intent-to-Treat |
IVD |
In Vitro Device, In Vitro Diagnostics |
JAN |
Japanese Adopted Names |
JPMA |
Japan Pharmaceutical Manufacturer's Association |
KS |
Kaposi's Sarcoma |
LACF |
Low Acid Canned Food |
LCDC |
Laboratory Centre for Disease Control (Canada) |
LOA |
Letter of Agreement |
LS |
Labelling Standard (Canada) |
MA |
Marketing Authorization |
MAD |
Multiple Ascending Dose |
MAH |
Marketing Authorisation Holder (EC) |
MAPP |
Manual of Policy and Procedure |
MCA |
Medicines Control Agency (UK) |
MDA |
Medical Devices Agency (UK) |
MDB |
Medical Devices Bureau (Canada) |
MDDs |
Medical Device Directives |
MDI |
Metered Dose Inhaler |
MDMA |
Medical Device Manufacturers Association |
MDP |
Medical Devices Program (Canada) |
MDR |
Medical Device Reporting |
MDV |
Medical Device Vigilance |
MDD |
Medical Devices Directives (EU) |
MEDEC |
Medical Devices Canada |
MEFA |
The Association of the Danish Pharmaceutical Industry |
MEMO |
Medicines Evaluation and Monitoring Organization |
MHW |
Ministry of Health and Welfare (Japan's Drug Regulatoy Agency) |
MLD |
Minimal Lethal Dose |
MOU |
Memorandum of Understanding |
MPA |
Medical Products Agency (Sweden) |
MPA |
Multiple Project Assurance |
MRA |
Mutual Recognition Agreements |
MRD |
Multiple Rising Dose |
MRFG |
Mutual Recognition Facilitating Group |
MRI |
Magnetic Resonance Imaging |
MQSA |
Mammography Quality Standards Act of 1992 |
MTD |
Maximum Tolerated Dose |
NADA |
New Animal Drug Application |
NAF |
Notice of Adverse Findings (FDA Post-audit Letter) |
NAFTA |
North American Free Trade Agreement |
NAI |
No Action Indicated (favorable FDA post- inspection classification) |
NAM |
National Agency for Medicines (Finland) |
NBs |
Notified Bodies (EU) |
NCBI |
National Center for Biotechnology Information |
NCCLS |
National Committee of Clinical Laboratory Standards |
NCE |
New Chemical Entity |
NCHS |
National Center for Health Statistics (in CDC) |
NCI |
National Cancer Institute |
NCPIE |
National Council on Patient Information and Education |
NCTR |
National Center for Toxicological Research |
NDA |
New Drug Application |
NDAB |
National Drugs Advisory Board (Ireland) |
NDAC |
Nonprescription Drug Advisory Committee |
NDS |
New Drug Submission (Canada) |
NEFARMA |
The Dutch Association of the Innovative Pharmaceutical Industry |
NHIS |
National Institute of Hygienic Sciences (Japan) |
NIAID |
National Institute of Allergies and Infectious Diseases (NIH) |
NIH |
National Institutes of Health |
NINDS |
National Institute of Neurological Disorders & Stroke (NIH) |
NLEA |
Nutrition Labeling and Education Act of 1990 |
NLN |
Nordic Council on Medicines |
NME |
New Molecular Entity |
NMI |
Non-medicinal Ingredients |
NMFS |
National Marine Fisheries Service |
NOC |
Notice of Compliance (Canada) |
NOD |
Notice of Deficiency (Canada) |
NOMI |
Federation of Norwegian Pharmaceutical Manufacturers |
NON |
Notice of Non-Compliance (Canada) |
NPA |
The National Pharmaceutical Association (UK) |
NRB |
Noninstitutional Review Board |
NRC |
Nuclear Regulatory Commission |
NSAID |
Nonsteroidal Anti-inflammatory Drug |
NTA |
Notice to Applicants (EC) |
NTCR |
National Center for Toxicological Research |
OAI |
Official Action Indicated (Serious FDA post-inspection Classification) |
OASIS |
Operational and Administrative System for Import Support |
OC |
Office of the Commissioner |
OCA |
Office of Consumer Affairs |
OCI |
Office of Criminal Investigation |
ODE |
Office of Device Evaluation (CDRH) |
ODE |
Office of Drug Evaluation |
OEF |
Greece's National Drug Organisation |
OEI |
Official Establishment Inventory |
OGD |
Office of Generic Drugs |
OHA |
Office of Health Affairs |
OLA |
Office of Legislative Affairs |
OPA |
Office of Public Affairs |
OPE |
Office of Planning and Evaluation |
OPRR |
Office of Protection from Research Risks |
ORA |
Office of Regulatory Affairs |
ORI |
Office of Research Integrity |
ORM |
Office of Review Management |
OTC |
Over-the-Counter (drugs) |
PAAB |
Pharmaceutical Advertising Advisory Board (Canada) |
PAB |
Pharmaceutical Affairs Bureau (Japan) |
PAG |
Project Advisory Group |
PAS |
Public Affairs Specialist |
PCC |
Poison Control Center |
PCERT |
Preclinical and Clinical Evaluation Review Template (Canada) |
PD |
Pharmacodynamics |
PDA |
Parenteral Drug Association |
PDMA |
Prescription Drug Marketing Act |
PDP |
Product Development Protocols (for medical devices) |
PDR |
Physician's Desk Reference |